| |
| |
|
| Insider
Information: |
Harrison Seth Loring |
| Relationship: |
Director |
| City: |
Sydney, Nsw |
| State: |
C3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
10,594,431 |
|
|
Indirect Shares
|
25,221,855 |
|
|
| Direct
Value |
$5,050,848 |
|
|
|
Indirect Value
|
$20,413,164 |
|
|
| Total
Shares |
35,816,286 |
|
|
| Total
Value |
$25,464,011 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
HeartWare International Inc |
HTWR |
Director |
2016-08-23 |
0 |
2016-08-23 |
0 |
Premium* |
|
|
Titan Pharmaceuticals Inc |
TTNP |
10% Owner |
2013-11-25 |
9,650,000 |
|
0 |
Premium* |
|
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
Director, 10% Owner |
2014-09-22 |
212,694 |
2014-09-22 |
7,912,079 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
Director, 10% Owner |
2015-10-20 |
595,436 |
2015-10-20 |
0 |
Premium* |
|
|
Stoke Therapeutics, Inc. |
STOK |
Director, 10% Owner |
2019-06-21 |
0 |
2020-11-24 |
17,161,713 |
Premium* |
|
|
Akero Therapeutics, Inc. |
AKRO |
Director |
2022-11-30 |
136,301 |
2022-11-30 |
148,063 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HTWR |
HeartWare International I... |
Director |
– • – |
2013-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
47,701 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2013-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
48,034 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2013-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
48,284 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2013-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
59,200 |
16,186 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2013-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
105,136 |
153,420 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2013-05-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(376,768) |
0 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2013-07-01 |
4 |
S |
$95.29 |
$1,253,734 |
D/D |
(13,118) |
140,302 |
0 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
10% Owner |
– – • |
2013-11-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,650,000 |
|
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2014-01-06 |
4 |
AS |
$99.29 |
$785,285 |
D/D |
(7,909) |
132,393 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2014-01-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,250 |
3,500 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2014-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
500 |
132,893 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2014-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
133,143 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
Director |
– • • |
2014-09-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
212,694 |
|
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
Director |
– • • |
2014-09-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9 |
|
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
Director |
– • • |
2014-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
7,549,570 |
7,549,579 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
Director |
– • • |
2014-09-22 |
4 |
B |
$15.00 |
$5,437,500 |
I/I |
362,500 |
7,912,079 |
2.25 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2015-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
134,643 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2015-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
134,893 |
0 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Director |
– • • |
2015-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
595,436 |
595,436 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2016-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
500 |
132,393 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2016-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
133,393 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2016-08-23 |
4 |
D |
$58.00 |
$1,069,288 |
I/I |
(18,436) |
0 |
0 |
- |
|
| HTWR |
HeartWare International I... |
Director |
– • – |
2016-08-23 |
4 |
D |
$58.00 |
$7,736,794 |
D/D |
(133,393) |
0 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • • |
2019-06-21 |
4 |
A |
$0.00 |
$0 |
I/I |
15,397,824 |
15,397,824 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • • |
2019-06-21 |
4 |
B |
$18.00 |
$25,000,002 |
I/I |
1,388,889 |
16,786,713 |
2.25 |
- |
|
89 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
